TABLE 1.
Oligonucleotides used in this work
Name | Sequence (5′ → 3′)a |
---|---|
pri-miR-372 sense | GTTACGGATCCAGATCTCTCAACCTGCGGAGAAGATAC |
pri-miR-372 antisense | CAGCCGAATTCTGTAAGGGACCTGTACCCAAGACAG |
Cyclin A1 forward | GCGGATCCTTGCCTGAGTGAGC |
Cyclin A1 reverse | GCGAATTCGCAGAAGCCTATGA |
CDK2 forward | GCGAATTCCCCAGCCCTAATCTCA |
CDK2 reverse | GCCTCGAGAACCCTCTTCAGCAATAA |
CyclinA1-mut forward | CTGAATGGATGGAGTACCAGAACTTC |
CyclinA1-mut reverse | GAAGTTCTGGTACTCCATCCATTCAG |
CDK2-mut forward | GTATTAGATGGTCATAAGTTAGCC |
CDK2-mut reverse | GGCTAACTTATGACCATCTAATAC |
U6-RT | GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAAAATATGGAAC |
miR-372-RT | GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACGCTC |
U6 forward | TGCGGGTGCTCGCTTCGGCAGC |
miR-372 forward | GCCCGCAAAGTGCTGCGACAT |
Reverse (universal) | CCAGTGCAGGGTCCGAGGT |
Actin forward | CGTGACATTAAGGAGAAGCTG |
Actin reverse | CTAGAAGCATTTGCGGTGGAC |
a Restriction sites are underlined.